News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Emma Forkner, MS

Articles by Emma Forkner, MS

Cost-effectiveness of Telephonic Disease Management in Heart Failure

ByBrad Smith, PhD,Paul F. Hughes-Cromwick, MA,Emma Forkner, MS,Autumn Dawn Galbreath, MD

February 15th 2008

This study shows that telephonic disease management was not cost-effective in a broadly representative sample of community-dwelling patients.

Disease Management Produces Limited Quality-of-life Improvements in Patients With Congestive Heart Failure: Evidence From a Randomized Trial in Community-dwelling Patients

ByBrad Smith, PhD,Emma Forkner, MS,Barbara Zaslow, BSN,Richard A. Krasuski, MD,Karl Stajduhar, MD,Michael Kwan, MD,Robert Ellis, MD,Autumn Dawn Galbreath, MD,Gregory L. Freeman, MD

November 1st 2005

Latest Updated Articles

Disease Management Produces Limited Quality-of-life Improvements in Patients With Congestive Heart Failure: Evidence From a Randomized Trial in Community-dwelling Patients
Published: November 1st 2005 | Updated:
Cost-effectiveness of Telephonic Disease Management in Heart Failure
Published: February 15th 2008 | Updated:

Trending on AJMC

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

Brensocatib Reduced Symptom Burden, Neutrophil Serine Proteases Activity in Bronchiectasis

Pembrolizumab Plus Chemo Boosts PFS, OS in Platinum-Resistant Recurrent Ovarian Cancer: Nicoletta Colombo, MD, PhD

Long-Term Data for PHAROS Show Half of Treatment-Naïve Patients Receiving Encorafenib Plus Binimetinib Alive at 4 Years

Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.